
Anti-CD4 Therapy Boosts CD8+ Immunity, Halts Lung Cancer
A groundbreaking study has emerged from the laboratories of Nishioka, Sakabe, Kitabatake, and their colleagues, revealing a remarkable therapeutic avenue for combating lung cancer complicated by pulmonary fibrosis. Their research demonstrates that targeting






